Skip to main content
Fig. 11 | Acta Neuropathologica Communications

Fig. 11

From: Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation

Fig. 11

Kaplan–Meier survival curves for patients with GBM stratified by high or low PROM1 (separated at the median level) and MGMT methylation status (upper panel). The high PROM1/methylated group has the longest survival of the four groups. Kaplan–Meier survival curves for patients with GBM comparing high PROM1/methylated patients to all other groups combined (lower panel)

Back to article page